Antiviral T-Cells for Adenovirus in the Pre-Transplant Period: a Bridge Therapy for Severe Combined Immunodeficiency

Miller HK1, Hanley PJ2, Lang H3, Lazarski CA3, Chorvinsky EA3, McCormack S3, Roesch L4, Albihani S3, Dean M3, Hoq F3, Adams RH1, Bollard CM2, Keller MD5. 1Division of Blood and Marrow Transplantation, Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona; Blood and Marrow Transplant, Division of Internal Medicine, Mayo Clinic Arizona, Phoenix, Arizona. 2Center for Cancer and Immunology Research, Children's National Health System, Washington, DC; Division of Blood and Marrow Transplantation, Children's National Health System, Washington, DC. 3Center for Cancer and Immunology Research, Children's National Health System, Washington, DC. 4Division of Blood and Marrow Transplantation, Children's National Health System, Washington, DC. 5Center for Cancer and Immunology Research, Children's National Health System, Washington, DC; Division of Allergy & Immunology, Children's National Health System, Washington, DC.